Scientists Develop Yeast-Based Production of Ashwagandha Compounds

Researchers have engineered a strain of yeast to produce withanolides, the active compounds found in ashwagandha (Withania somnifera), a traditional herbal medicine used for centuries in Indian medicine. This breakthrough could significantly streamline the production of ashwagandha supplements, which have gained popularity recently as remedies for stress and anxiety, largely due to endorsements from social media and celebrities. The conventional method of cultivating the entire ashwagandha plant for its roots is labor-intensive and time-consuming. The new yeast-based approach offers a more efficient alternative.

ScienceAlert

The research team, led by Jing-Ke Weng, a bioengineer at Northeastern University, sequenced the ashwagandha genome to identify six genes responsible for synthesizing withanolides. By splicing these genes into the yeast genome, the scientists successfully prompted the yeast to produce these compounds within days. Currently, the yeast generates intermediate molecules at a concentration of milligrams per liter, marking a significant step toward scaling up production for medicinal and research applications.

ScienceAlert

The ability to produce withanolides in bulk could have profound implications for the expanding ashwagandha market, which encompasses a range of products from dietary supplements to anti-anxiety beverages. While the most robust evidence supports ashwagandha's effectiveness in alleviating stress and anxiety, other purported benefits, such as enhanced physical performance and cognitive function, lack substantial scientific backing. The new production method may facilitate further research into these claims, potentially validating or refuting them.

ScienceAlert

Weng expressed optimism about the future of this technology, stating, "In the future, we can foresee that we don't have to grow the plants to get withanolides. We can simply engineer and optimize this yeast strain to produce the very precise analog we want." This advancement could pave the way for new drug discovery and development.

ScienceAlert

Despite the promising nature of this research, there are concerns regarding the safety and efficacy of ashwagandha products. While some studies suggest benefits, they also indicate potential side effects, including nausea, diarrhea, and, at higher doses, liver toxicity. Critics argue that the rapid commercialization of ashwagandha supplements may outpace the scientific validation of their health claims, emphasizing the need for rigorous clinical trials.

ScienceAlert

The research findings were published in the journal *Nature Plants*, highlighting the potential for yeast-engineered production methods to revolutionize the way withanolides are sourced. The study represents a significant advancement in biotechnology and its application in herbal medicine.

ScienceAlert

• "We not only discovered the pathway through this yeast engineering approach, but by the end of this paper we have a prototype yeast strain that can be industrialized to produce withanolides." — Jing-Ke Weng, Bioengineer, Northeastern University

ScienceAlert

• "In the future, we can foresee that we don't have to grow the plants to get withanolides." — Jing-Ke Weng, Bioengineer, Northeastern University

ScienceAlert

This innovative approach to producing ashwagandha compounds could reshape the industry, but it also raises important questions about safety and the need for further research.

ScienceAlert